Table 1. Characteristic features of various forms of hypophosphatemic rickets.
XLHR | ADHR | ARHR1 ARHR2 |
HHRH | NPHLOP1 NPHLOP2 | HRH | |
---|---|---|---|---|---|---|
Gene involved | PHEX | FGF23 | DMP1 and ENPP1, respectively | SLC34A3 | SLC34A1 and SLC9A3R1, respectively | KL |
Chromosomal location | Xp22.1 | 12p13 | 4q22.1 and 6q23.2 | 9q34.3 | 5q35.3 and 17q25.1 | 13q13.1 |
Inheritance | X-linked dominant | Autosomal dominant | Autosomal recessive | Autosomal recessive | Autosomal dominant | Autosomal dominant |
Type of mutation | Loss of function | Gain of function | Loss of function | Loss of function | Loss of function | Chromosomal translocation t (9;13)(q21.13;q13.1) |
Pathogenesis | PHEX mutations raise FGF23 levels causing renal phosphate wasting | Mutated FGF23 becomes resistant to proteolytic inactivation, increasing FGF23 levels, causing renal phosphate wasting | DMP1 and ENPP1 mutations increase FGF23 levels causing renal phosphate wasting | SLC34A3 mutations decrease renal phosphate reabsorption causing renal phosphate wasting |
Inactivating
SLC34A1
and
SLC9A3R1
mutations decrease renal phosphate reabsorption causing renal phosphate wasting |
Chromosomal translocation breakpoint adjacent to α-Klotho results in elevated circulatory α-Klotho and FGF23 levels causing renal phosphate wasting and hyperparathyroidism |
Serum phosphorus | Low | Low | Low | Low | Low | Low |
Urine phosphorus | High | High | High | High | High | High |
Serum calcium | Normal | Normal | Normal | Normal/High | Normal | Normal/High |
Urine calcium | Low/Normal | Low/Normal | Low/Normal | High | High | Normal/High |
Serum FGF23 level | High | High | High | Normal | Normal | High |
1,25 (OH) 2 vitamin D 3 level | Low/Normal | Low/Normal | Low/Normal | High | High | Low/Normal |
Parathyroid hormone | Normal/High | Normal | Normal | Low | Low/Normal | High |
TmP/GFR a | Low | Low | Low | Low | Low | Low |
Muscle weakness | Minimal | Present | Minimal | Present | Present | Present |
Hypercalciuria | No | No | No | Yes | Yes | Yes |
Nephrolithiasis | No | No | No | Yes | Yes | Yes |
Nephrocalcinosis | No | No | No | Yes | Yes | Yes |
Abbreviations: ADHR, autosomal dominant hypophosphatemic rickets; ARHR, autosomal recessive hypophosphatemic rickets; FGF, fibroblast growth factor; GFR, glomerular filtration rate; HRH, hypophosphatemic rickets with hyperparathyroidism; HHRH, hereditary hypophosphatemic rickets with hypercalciuria; NPHLOP, hypophosphatemic nephrolithiasis/osteoporosis type; TmP, tubular maximum reabsorption of phosphate; XLHR, X-linked hypophosphatemic rickets.